(Q46933007)

26 December 2017

title

Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis (English)

1 reference

26 December 2017

primary sclerosing cholangitis

main subject

ascending cholangitis

0 references

1 reference

inferred from title

author

Gideon M. Hirschfield

5

1 reference

26 December 2017

Malgorzata Milkiewicz

Malgorzata Milkiewicz

3

0 references

Piotr Milkiewicz

Piotr Milkiewicz

Joanna Raszeja-Wyszomirska

7

0 references

4

Joanna Raszeja-Wyszomirska

1 reference

26 December 2017

Ewa Wunsch

1

Ewa Wunsch

1 reference

26 December 2017

author name string

Jocelyn Trottier

2

1 reference

26 December 2017

Olivier Barbier

6

1 reference

26 December 2017

language of work or name

English

0 references

publication date

30 July 2014

1 reference

26 December 2017

published in

Hepatology

1 reference

26 December 2017

volume

60

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

931-940

1 reference

26 December 2017

Primary sclerosing cholangitis

cites work

1 reference

Liver transplantation in chronic cholestatic conditions

21 January 2018

1 reference

Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'.

21 January 2018

1 reference

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

21 January 2018

1 reference

Primary biliary cirrhosis

21 January 2018

1 reference

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

21 January 2018

1 reference

High-dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis: throwing the urso out with the bathwater?

21 January 2018

1 reference

Diagnosis and management of primary sclerosing cholangitis.

21 January 2018

1 reference

EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

21 January 2018

1 reference

High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis

21 January 2018

1 reference

Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids

21 January 2018

1 reference

Profiling serum bile acid glucuronides in humans: gender divergences, genetic determinants, and response to fenofibrate.

21 January 2018

1 reference

Profile of serum bile acids in noncholestatic volunteers: gender-related differences in response to fenofibrate

21 January 2018

1 reference

Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting

21 January 2018

1 reference

Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis

21 January 2018

1 reference

A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis

21 January 2018

1 reference

Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis

21 January 2018

1 reference

Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression

21 January 2018

1 reference

Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis

21 January 2018

1 reference

Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.

21 January 2018

1 reference

Intestinal absorption and biliary secretion of ursodeoxycholic acid and its taurine conjugate

21 January 2018

1 reference

Bile acid metabolism and the pathophysiology of cholestasis

21 January 2018

1 reference

Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice.

21 January 2018

1 reference

The effect of lithocholic acid on proliferation and apoptosis during the early stages of colon carcinogenesis: differential effect on apoptosis in the presence of a colon carcinogen

21 January 2018

1 reference

Role of bile acids in colorectal carcinogenesis

21 January 2018

1 reference

Bile Acid sulfation: a pathway of bile acid elimination and detoxification

21 January 2018

1 reference

Detoxification of lithocholic acid, a toxic bile acid: relevance to drug hepatotoxicity

21 January 2018

1 reference

The FGF family: biology, pathophysiology and therapy

21 January 2018

1 reference

Identification of a hormonal basis for gallbladder filling.

21 January 2018

1 reference

Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes.

21 January 2018

1 reference

Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity

21 January 2018

1 reference

Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis

21 January 2018

1 reference

Liver-specific activities of FGF19 require Klotho beta

21 January 2018

1 reference

FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways

21 January 2018

1 reference

High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study

21 January 2018

1 reference

Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study

21 January 2018

1 reference

7 January 2021

Assessment of Pruritus Intensity: Prospective Study on Validity and Reliability of the Visual Analogue Scale, Numerical Rating Scale and Verbal Rating Scale in 471 Patients with Chronic Pruritus

1 reference

7 January 2021

Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial

1 reference

7 January 2021

Ursodeoxycholic acid for primary sclerosing cholangitis

1 reference

7 January 2021

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

1 reference

7 January 2021

Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health

1 reference

7 January 2021

Ileal excretion of bile acids: Comparison with biliary bile composition and effect of ursodeoxycholic acid treatment

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.27074

1 reference

26 December 2017

1 reference

26 December 2017